Dr. Lee Schwamm, vice president of virtual care/digital health at Mass General Brigham said this at the virtual event World Medical Innovation Forum hosted by Partners HealthCare on Monday.
Despite continued economic impacts from the Covid-19 pandemic, biotechnology companies and VC firms raised significant amounts of funding this week. For example, Massachusetts-based Pandion Therapeutics closed $80 million in funding to develop a therapeutic designed to treat autoimmune diseases.
Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S.
AristaMD, a San Diego-based startup facilitating eConsults, raised $18 million in a series B round led by Cigna Ventures and MemorialCare Innovation Fund. The company plans to use the additional funds to expand its footprint across the U.S.
Rebecca Cofinas, AristaMD CEO, said in response to emailed questions: "We see ourselves as experts focused on a single but critical issue. We dramatically improve the specialist referral process and allow physicians to collaborate in real-time."